Wed, June 25, 2025
Tue, June 24, 2025
[ Tue, Jun 24th ]: 13abc
Moment of Science: Copper
Mon, June 23, 2025
Sun, June 22, 2025
Sat, June 21, 2025
Fri, June 20, 2025
Thu, June 19, 2025
Wed, June 18, 2025
Tue, June 17, 2025
[ Tue, Jun 17th ]: MLB
Yankees Mag: Life Sciences
Mon, June 16, 2025
Sun, June 15, 2025

New neuro company raises $140M for depression drug

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. uro-company-raises-140m-for-depression-drug.html
  Print publication without navigation Published in Science and Technology on by STAT
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
And other biotech news stories brought to you by The Readout.
The article from STAT News dated June 18, 2025, discusses several key developments in the biotech industry. It highlights Dr. Marty Makary's new book on the future of medicine, which emphasizes personalized treatments and the integration of AI in healthcare. The article also covers Draig Pharmaceuticals' promising results from their Phase 2 trial of a novel psychedelic compound aimed at treating depression, showing significant improvements in patient outcomes. Additionally, it mentions BioVaccines' advancement in developing a universal flu vaccine, which has entered Phase 3 trials. The piece concludes with a brief mention of The Readout newsletter, which provides weekly updates on biotech and pharmaceutical news.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/06/18/biotech-news-makary-draig-psychedelics-depression-bio-vaccines-the-readout/ ]